The use of radiosynovectomy in patients with juvenile idiopathic arthritis. Assessment of treatment efficacy and safety

被引:0
|
作者
Gazda, Agnieszka [1 ]
Cwikla, Jaroslaw [2 ]
Kotodziejczyk, Beata [1 ]
Szczygielska, Izabela [1 ]
Hernik, Elzbieta [1 ]
Gietka, Piotr [1 ]
Rutkowska-Sak, Lidia [1 ]
机构
[1] Natl Inst Geriatr Rheumatol & Rehabil, Clin Dev Age Rheumatol, 1 Spartanska St, PL-02637 Warsaw, Poland
[2] Gammed Diagnost & Treatment Ctr, Warsaw, Poland
来源
REUMATOLOGIA | 2021年 / 59卷 / 04期
关键词
Intraarticular injection; Juvenile idiopathic arthritis; Local treatment; Radiosynovectomy;
D O I
10.5114/reum.2021.108450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of the study was to evaluate the usefulness of knee joint radiosynovectomy (RS) in patients suffering from juvenile idiopathic arthritis (JIA). Material and methods: One hundred RS procedures performed in 58 patients with JIA in average age 10.4 years were evaluated. Results: After 6 weeks, a decrease in the number of cases with joint pain from 90.3% to 29%, with joint oedema from 100% to 74.5%, with joint exudate from 100% to 60.6%, with gait disorders from 19.4% to 3.2%, with joint mobility disorders from 51.1% to 26.6% in the RS cases was observed. A reduction of the score in the Colorado scale from 10.9 to 4.66, in the pain visual analogue scale (VAS) from 50 to 10, in the illness VAS assessed by the patient/parent from 69.9 to 32.4, in the illness VAS assessed by the physician from 68.8 to 36.9 was observed. Six months after the RS procedure, a reduction in the number of cases with joint pain from 89.5% prior to the procedure to 29.5%, with oedema from 100% to 58.3%, with exudate from 100% to 46.9%, with gait disorders from 20% to 2.1%, with joint motility disorders from 51.1% to 26.1% was achieved. The score in the Colorado scale was reduced from 10.9 to 4.04, in the pain VAS from 40 to 0, in the illness VAS assessed by the patient/parent from 69.7 to 27.9, in the illness VAS assessed by the physician from 68.8 to 32.4. In ultrasound examinations, the greatest improvement compared to the initial condition was recorded in the 6th month after the RS. Radiosynovectomy was positively evaluated by parents and patients in 34 anonymous surveys. Early and late observations (average 1473 days) did not show lesions at the isotope injection site, and no neoplastic lesions were observed. Conclusions: Radiosynovectomy is a valuable therapeutic option for local treatment in patients with JIA.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [21] Efficacy and safety of treatment with Infliximab in patients with early Oligo- and Polyarticular Juvenile Idiopathic Arthritis
    Mitenko, Elena
    Alexeeva, Ekaterina
    Valieva, Sanya
    Bzarova, Tatyana
    Sleptsova, Tatyana
    Isaeva, Kseniya
    Lisitsyn, Alexander
    Denisova, Rina
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 439 - 439
  • [22] Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
    Murdaca, Giuseppe
    Negrini, Simone
    Magnani, Ottavia
    Penza, Elena
    Pellecchio, Marco
    Gulli, Rossella
    Mandich, Paola
    Puppo, Francesco
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 417 - 431
  • [23] Safety of tocilizumab in the treatment of juvenile idiopathic arthritis
    Machado, Sandra Helena
    Xavier, Ricardo Machado
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 493 - 500
  • [24] Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
    E Alexeeva
    R Denisova
    S Valieva
    T Bzarova
    K Isayeva
    T Sleptsova
    E Mitenko
    Pediatric Rheumatology, 9 (Suppl 1)
  • [25] Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis
    Lanlan Ge
    Yu Gao
    Xin Chen
    Jingxiao Guo
    Dongfeng Zhang
    Yanjun Yang
    BMC Pediatrics, 25 (1)
  • [26] EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
    Schmeling, H.
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 71 - 71
  • [27] The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis
    Cakan, Mustafa
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Tanatar, Ayse
    NORTHERN CLINICS OF ISTANBUL, 2020, 7 (02) : 118 - 123
  • [28] Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
    Arina Lazareva
    Valda Stanevicha
    Jelizaveta Semjonova
    Ruta Shantere
    Inita Buliņa
    Pediatric Rheumatology, 9 (Suppl 1)
  • [29] Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
    Ravelli, A
    Migliavacca, D
    Viola, S
    Ruperto, N
    Pistorio, A
    Martini, A
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S184 - S184
  • [30] Serum Sclerostin in Juvenile Idiopathic Arthritis.
    Stepan, Jan
    Maresova, Kristyna Brabnikova
    Jarosova, Katerina
    Pavelka, Karel
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S256 - S256